Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023

Author:

Link-Gelles Ruth,Ciesla Allison Avrich,Rowley Elizabeth A.K.,Klein Nicola P.,Naleway Allison L.,Payne Amanda B.,Kharbanda Anupam,Natarajan Karthik,DeSilva Malini B.,Dascomb Kristin,Irving Stephanie A.,Zerbo Ousseny,Reese Sarah E.,Wiegand Ryan E.,Najdowski Morgan,Ong Toan C.,Rao Suchitra,Stockwell Melissa S.,Stephens Ashley,Goddard Kristin,Martinez Yessica C.,Weber Zachary A.,Fireman Bruce,Hansen John,Timbol Julius,Grannis Shaun J.,Barron Michelle A.,Embi Peter J.,Ball Sarah W.,Gaglani Manjusha,Grisel Nancy,Arndorfer Julie,Tenforde Mark W.,Fleming-Dutra Katherine E.

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology

Reference9 articles.

1. Interim recommendations of the Advisory Committee on Immunization Practices for use of Moderna and Pfizer-BioNTech COVID-19 vaccines in children aged 6 months–5 years—United States, June 2022.;Fleming-Dutra;MMWR Morb Mortal Wkly Rep,2022

2. National Center for Health Statistics. Provisional COVID-19 death counts by age in years, 2020–2022. Hyattsville, MD: US Department of Health and Human Services, CDC; 2022. Accessed July 26, 2023. https://data.cdc.gov/d/3apk-4u4f

3. Evaluation of mRNA-1273 vaccine in children 6 months to 5 years of age.;Anderson;N Engl J Med,2022

4. Food and Drug Administration; Vaccines and Related Biological Products Advisory Committee. FDA briefing document: EUA amendment request for Pfizer-BioNTech COVID-19 vaccine for use in children 6 months through 4 years of age. Presented at the Vaccines and Related Biological Products Advisory Committee meeting, Silver Spring, MD; June 15, 2022. https://www.fda.gov/media/159195/download

5. CDC. Vaccines & immunizations: use of COVID-19 vaccines in the United States. Atlanta, GA: US Department of Health and Human Services, CDC, 2023. Accessed January 18, 2023. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3